Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
GDRX
GDRX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
GDRX News
GoodRx Launches FDA-Approved Foundayo Medication for Weight Management
Apr 09 2026
Newsfilter
GoodRx Stock Jumps 5.1% in Premarket Trading Following Announcement of Self-Pay Access to Eli Lilly's New Weight-Loss Medication
Apr 09 2026
moomoo
GOODRX INCREASES AVAILABILITY OF ELI LILLY'S NEW ORAL GLP-1, FOUNDAYO™, AND ZEPBOUND® KWIKPEN® WITH SELF-PAY PRICING AT OVER 70,000 PHARMACIES ACROSS THE COUNTRY
Apr 09 2026
moomoo
GoodRx Partners with Viatris to Offer Up to 85% Discounts on Medications
Mar 11 2026
seekingalpha
GOODRX TEAMS UP WITH VIATRIS TO PROVIDE UP TO 85% DISCOUNTS ON WELL-KNOWN BRAND MEDICATIONS
Mar 11 2026
moomoo
GoodRx Partners with Eli Lilly to Lower Medication Costs
Mar 06 2026
Newsfilter
GoodRx Holdings Inc. Enables Self-Insured Employers to Offset $449 Lilly Price for Zebound KwikPen Through GoodRx
Mar 06 2026
moomoo
GoodRx Holdings Inc. Partners with Eli Lilly to Enhance Employer Access to Zepbound KwikPen
Mar 06 2026
moomoo
GOODRX TO BROADEN EMPLOYER-SPONSORED AVAILABILITY OF ZEPBOUND® KWIKPEN®
Mar 06 2026
moomoo
Eli Lilly Launches New Program to Enhance Obesity Drug Coverage
Mar 05 2026
CNBC
GoodRx Q4 2025 Earnings Call Highlights
Feb 26 2026
seekingalpha
Marriott Vacations Reports Strong Q4, Shares Surge
Feb 26 2026
Benzinga
Market Sentiment Shift Creates Opportunities
Feb 06 2026
Benzinga
GoodRx Becomes Major Integration Partner for Pfizer on TrumpRx
Feb 06 2026
seekingalpha
Amazon Enters GLP-1 Drug Market, Competing with Pharma Giants
Feb 06 2026
Fool
GoodRx Partners with TrumpRx to Launch Drug Discounts
Feb 06 2026
Newsfilter
Show More News